NCOA2 Antikörper
Kurzübersicht für NCOA2 Antikörper (ABIN2853801)
Target
Alle NCOA2 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
Klon
-
-
Produktmerkmale
- Mouse Monoclonal antibody to human TIF2
-
Isotyp
- IgG1 kappa
-
-
anti-Nuclear Receptor Coactivator 2 (NCOA2) (AA 550-820) antibody
NCOA2 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Nuclear Receptor Coactivator 2 (NCOA2) (N-Term) antibodyNCOA2 Reaktivität: Human, Maus, Ratte, Hund, Kaninchen, Rind (Kuh), Meerschweinchen, Pferd, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
anti-Nuclear Receptor Coactivator 2 (NCOA2) (AA 706-739) antibodyNCOA2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB54073 unconjugated
anti-Nuclear Receptor Coactivator 2 (NCOA2) (AA 1169-1203), (C-Term) antibodyNCOA2 Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal RB50717 unconjugated
anti-Nuclear Receptor Coactivator 2 (NCOA2) (AA 1431-1462) antibodyNCOA2 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB53913 unconjugated
anti-Nuclear Receptor Coactivator 2 (NCOA2) (C-Term) antibodyNCOA2 Reaktivität: Human, Maus WB, IHC, IP, IHC (p), IF, PLA Wirt: Kaninchen Polyclonal unconjugated
anti-Nuclear Receptor Coactivator 2 (NCOA2) (N-Term) antibodyNCOA2 Reaktivität: Human, Maus, Ratte, Hund, Kaninchen, Pferd, Schwein, Fledermaus, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Nuclear Receptor Coactivator 2 (NCOA2) (AA 702-751), (pSer736) antibodyNCOA2 Reaktivität: Human WB, IHC, ELISA Wirt: Kaninchen Polyclonal unconjugated
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Handhabung
- Aliquot to avoid repeated freezing and thawing.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20 °C.
-
-
- NCOA2 (Nuclear Receptor Coactivator 2 (NCOA2))
-
Andere Bezeichnung
- TIF2
-
Pathways
- Intracellular Steroid Hormone Receptor Signaling Pathway, Regulation of Intracellular Steroid Hormone Receptor Signaling, Nuclear Hormone Receptor Binding, Regulation of Lipid Metabolism by PPARalpha, Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, CXCR4-mediated Signaling Events, Thromboxane A2 Receptor Signaling
Target
-
